| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 1546 |
| 1 | RUCAPARIB | 517 |
| 2 | OLAPARIB | 210 |
| 3 | BEVACIZUMAB | 168 |
| 4 | ERGOCALCIFEROL | 148 |
| 5 | LORAZEPAM | 124 |
| 6 | GABAPENTIN | 114 |
| 7 | LISINOPRIL | 105 |
| 8 | LEVOTHYROXINE SODIUM | 96 |
| 9 | METOPROLOL | 95 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIPERINE | 1 | 0.2000 |
| 1 | FERRIC SUBSULFATE | 1 | 0.1250 |
| 2 | NIRAPARIB | 1546 | 0.1050 |
| 3 | RUCAPARIB | 517 | 0.0688 |
| 4 | DEXTROSE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | 1 | 0.0286 |
| 5 | OLAPARIB | 210 | 0.0217 |
| 6 | PASSION FLOWER | 1 | 0.0133 |
| 7 | SHARK CARTILAGE | 1 | 0.0132 |
| 8 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0122 |
| 9 | METHENAMINE, SODIUM SALICYLATE | 1 | 0.0122 |
| # | Drug class | Count |
|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1747 |
| 1 | Benzodiazepine [EPC] | 202 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 174 |
| 3 | Provitamin D2 Compound [EPC] | 151 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 144 |
| 5 | Anti-epileptic Agent [EPC] | 129 |
| 6 | Platinum-based Drug [EPC] | 98 |
| 7 | Factor Xa Inhibitor [EPC] | 91 |
| 8 | Corticosteroid [EPC] | 89 |
| 9 | Proton Pump Inhibitor [EPC] | 82 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1747 | 0.0718 |
| 1 | Phenothiazine [EPC] | 41 | 0.0020 |
| 2 | Cannabinoid [EPC] | 11 | 0.0015 |
| 3 | Methylating Agent [EPC] | 1 | 0.0014 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 174 | 0.0013 |
| 5 | Aromatase Inhibitor [EPC] | 77 | 0.0009 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 72 | 0.0009 |
| 7 | alpha-Hydroxy Acid [EPC] | 1 | 0.0008 |
| 8 | Platinum-based Drug [EPC] | 98 | 0.0006 |
| 9 | Calcium [EPC] | 65 | 0.0006 |